methylmalonic acidemia
Information
- Disease name
- methylmalonic acidemia
- Disease ID
- DOID:14749
- Description
- "An organic acidemia that involves an accumulation of methylmalonic acid in the blood." [url:http\://ghr.nlm.nih.gov/condition/methylmalonic-acidemia]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT05506254 | Active, not recruiting | Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy | July 20, 2022 | December 31, 2037 | |
NCT01599286 | Completed | Phase 2 | Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia | September 1, 2012 | April 30, 2020 |
NCT03484767 | Completed | "The MaP Study": Mapping the Patient Journey in MMA and PA | March 20, 2018 | May 29, 2021 | |
NCT02426775 | Completed | Phase 3 | Carglumic Acid in Methylmalonic Acidemia and Propionic Acidemia | November 2015 | March 19, 2019 |
NCT00078078 | Recruiting | Clinical and Laboratory Study of Methylmalonic Acidemia | June 7, 2004 | ||
NCT04176523 | Recruiting | Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach | January 15, 2019 | July 30, 2029 | |
NCT04899310 | Recruiting | Phase 1/Phase 2 | A Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia | August 6, 2021 | August 1, 2028 |
NCT05040178 | Recruiting | An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics | June 30, 2022 | June 30, 2032 | |
NCT05295433 | Recruiting | Phase 1/Phase 2 | An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705 | March 8, 2022 | April 2, 2034 |
NCT01597440 | Terminated | Phase 2 | Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia | September 2012 | February 2015 |
NCT04836494 | Terminated | Phase 1 | A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic Acidemia | March 25, 2021 | November 20, 2023 |
NCT05438485 | Terminated | Natural History Study of Patients With Methylmalonic Acidemia and Propionic Acidemia | August 27, 2021 | October 20, 2023 | |
NCT04581785 | Terminated | Phase 1/Phase 2 | Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia | May 29, 2021 | January 10, 2023 |
NCT04732429 | Terminated | Phase 2 | Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia | March 15, 2021 | October 20, 2023 |
NCT01289158 | Unknown status | Combined Malonic and Methylmalonic Aciduria (CMAMMA): Gene Identification and Outcome Study | February 2011 | February 2012 | |
NCT01341379 | Withdrawn | Phase 2 | Increasing Ureagenesis in Inborn Errors of Metabolism With N-Carbamylglutamate | December 2010 | August 2012 |
- Disase is a (Disease Ontology)
- DOID:0060159
- Cross Reference ID (Disease Ontology)
- GARD:7033
- Cross Reference ID (Disease Ontology)
- MESH:C537358
- Exact Synonym (Disease Ontology)
- methylmalonic aciduria
- HPO alt_id (Human Phenotype Ontology)
- HP:0003123
- HPO alt_id (Human Phenotype Ontology)
- HP:0008295
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002912